APO RESEARCH · REPORT
Biobanking
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Product & engineering
Understand the product.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Selected research
Market Structure
Global Biobanking Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
Read the full market overview
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Report Includes
This report provides an overview of the global Biobanking market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biobanking and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biobanking revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biobanking market size, projected growth trends, production technologies, key applications, and end-use industries.
Biobanking Segment by Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Biobanking Segment by Type
Equipment
Consumable
Biobanking Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Biobanking Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biobanking in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobanking industry.
Chapter 3: Detailed analysis of Biobanking companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobankingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment
- Consumable
Applications
- Virtual Biobanks
- Tissue Biobanks
- Population Biobanks
Companies covered
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Chart Industries
- Brooks Life Science
- Tecan Group
- QIAGEN
- BD
- Lifeline Scientific
- Hamilton
- So-Low
- TTP Labtech Ltd
- Biolife Solutions
- DNA Genotek
- Custom Biogenic Systems
- LVL Technologies
- BioRep
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biobanking Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Equipment
- 1.2.3 Consumable
- 1.3 Market Analysis by Application
- 1.3.1 Global Biobanking Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Virtual Biobanks
- 1.3.3 Tissue Biobanks
- 1.3.4 Population Biobanks
- 1.4 Global Market Growth Prospects
- 1.5 Global Biobanking Growth Trends by Region
- 1.5.1 Global Biobanking Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biobanking Market Size by Region (2021-2026)
- 1.5.3 Biobanking Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biobanking Market Dynamics
- 2.1 Biobanking Industry Trends
- 2.2 Biobanking Industry Drivers
- 2.3 Biobanking Industry Opportunities and Challenges
- 2.4 Biobanking Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biobanking Revenue by Company (2021-2026)
- 3.2 Global Biobanking Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biobanking Key Company Head office and Area Served
- 3.4 Global Biobanking Company, Product Type & Application
- 3.5 Global Biobanking Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biobanking Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biobanking Players Market Share by Revenue in 2025
- 3.6.3 2025 Biobanking Tier 1, Tier 2, and Tier 3
4 Biobanking Market by Type
- 4.1 Global Biobanking Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biobanking Market Size by Type (2021-2032)
- 4.3 Global Biobanking Market Size Share by Type (2021-2032)
5 Biobanking Market by Application
- 5.1 Global Biobanking Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biobanking Market Size by Application (2021-2032)
- 5.3 Global Biobanking Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher
- 6.1.1 Thermo Fisher Company Information
- 6.1.2 Thermo Fisher Business Overview
- 6.1.3 Thermo Fisher Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Biobanking Product Portfolio
- 6.1.5 Thermo Fisher Recent Developments
- 6.2 Beckman Coulter
- 6.2.1 Beckman Coulter Company Information
- 6.2.2 Beckman Coulter Business Overview
- 6.2.3 Beckman Coulter Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Beckman Coulter Biobanking Product Portfolio
- 6.2.5 Beckman Coulter Recent Developments
- 6.3 Panasonic
- 6.3.1 Panasonic Company Information
- 6.3.2 Panasonic Business Overview
- 6.3.3 Panasonic Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Panasonic Biobanking Product Portfolio
- 6.3.5 Panasonic Recent Developments
- 6.4 SOL Group
- 6.4.1 SOL Group Company Information
- 6.4.2 SOL Group Business Overview
- 6.4.3 SOL Group Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 SOL Group Biobanking Product Portfolio
- 6.4.5 SOL Group Recent Developments
- 6.5 Promega
- 6.5.1 Promega Company Information
- 6.5.2 Promega Business Overview
- 6.5.3 Promega Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Promega Biobanking Product Portfolio
- 6.5.5 Promega Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Merck Biobanking Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Greiner Bio One
- 6.7.1 Greiner Bio One Company Information
- 6.7.2 Greiner Bio One Business Overview
- 6.7.3 Greiner Bio One Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Greiner Bio One Biobanking Product Portfolio
- 6.7.5 Greiner Bio One Recent Developments
- 6.8 Chart Industries
- 6.8.1 Chart Industries Company Information
- 6.8.2 Chart Industries Business Overview
- 6.8.3 Chart Industries Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Chart Industries Biobanking Product Portfolio
- 6.8.5 Chart Industries Recent Developments
- 6.9 Brooks Life Science
- 6.9.1 Brooks Life Science Company Information
- 6.9.2 Brooks Life Science Business Overview
- 6.9.3 Brooks Life Science Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Brooks Life Science Biobanking Product Portfolio
- 6.9.5 Brooks Life Science Recent Developments
- 6.10 Tecan Group
- 6.10.1 Tecan Group Company Information
- 6.10.2 Tecan Group Business Overview
- 6.10.3 Tecan Group Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Tecan Group Biobanking Product Portfolio
- 6.10.5 Tecan Group Recent Developments
- 6.11 QIAGEN
- 6.11.1 QIAGEN Company Information
- 6.11.2 QIAGEN Business Overview
- 6.11.3 QIAGEN Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 QIAGEN Biobanking Product Portfolio
- 6.11.5 QIAGEN Recent Developments
- 6.12 BD
- 6.12.1 BD Company Information
- 6.12.2 BD Business Overview
- 6.12.3 BD Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 BD Biobanking Product Portfolio
- 6.12.5 BD Recent Developments
- 6.13 Lifeline Scientific
- 6.13.1 Lifeline Scientific Company Information
- 6.13.2 Lifeline Scientific Business Overview
- 6.13.3 Lifeline Scientific Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Lifeline Scientific Biobanking Product Portfolio
- 6.13.5 Lifeline Scientific Recent Developments
- 6.14 Hamilton
- 6.14.1 Hamilton Company Information
- 6.14.2 Hamilton Business Overview
- 6.14.3 Hamilton Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Hamilton Biobanking Product Portfolio
- 6.14.5 Hamilton Recent Developments
- 6.15 So-Low
- 6.15.1 So-Low Company Information
- 6.15.2 So-Low Business Overview
- 6.15.3 So-Low Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 So-Low Biobanking Product Portfolio
- 6.15.5 So-Low Recent Developments
- 6.16 TTP Labtech Ltd
- 6.16.1 TTP Labtech Ltd Company Information
- 6.16.2 TTP Labtech Ltd Business Overview
- 6.16.3 TTP Labtech Ltd Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 TTP Labtech Ltd Biobanking Product Portfolio
- 6.16.5 TTP Labtech Ltd Recent Developments
- 6.17 Biolife Solutions
- 6.17.1 Biolife Solutions Company Information
- 6.17.2 Biolife Solutions Business Overview
- 6.17.3 Biolife Solutions Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Biolife Solutions Biobanking Product Portfolio
- 6.17.5 Biolife Solutions Recent Developments
- 6.18 DNA Genotek
- 6.18.1 DNA Genotek Company Information
- 6.18.2 DNA Genotek Business Overview
- 6.18.3 DNA Genotek Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 DNA Genotek Biobanking Product Portfolio
- 6.18.5 DNA Genotek Recent Developments
- 6.19 Custom Biogenic Systems
- 6.19.1 Custom Biogenic Systems Company Information
- 6.19.2 Custom Biogenic Systems Business Overview
- 6.19.3 Custom Biogenic Systems Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Custom Biogenic Systems Biobanking Product Portfolio
- 6.19.5 Custom Biogenic Systems Recent Developments
- 6.20 LVL Technologies
- 6.20.1 LVL Technologies Company Information
- 6.20.2 LVL Technologies Business Overview
- 6.20.3 LVL Technologies Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 LVL Technologies Biobanking Product Portfolio
- 6.20.5 LVL Technologies Recent Developments
- 6.21 BioRep
- 6.21.1 BioRep Company Information
- 6.21.2 BioRep Business Overview
- 6.21.3 BioRep Biobanking Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.21.4 BioRep Biobanking Product Portfolio
- 6.21.5 BioRep Recent Developments
7 North America
- 7.1 North America Biobanking Market Size (2021-2032)
- 7.2 North America Biobanking Market Size by Type
- 7.2.1 North America Biobanking Market Size by Type (2021-2026)
- 7.2.2 North America Biobanking Market Size by Type (2027-2032)
- 7.2.3 North America Biobanking Market Share by Type (2021-2032)
- 7.3 North America Biobanking Market Size by Application
- 7.3.1 North America Biobanking Market Size by Application (2021-2026)
- 7.3.2 North America Biobanking Market Size by Application (2027-2032)
- 7.3.3 North America Biobanking Market Share by Application (2021-2032)
- 7.4 North America Biobanking Market Size by Country
- 7.4.1 North America Biobanking Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biobanking Market Size by Country (2021-2026)
- 7.4.3 North America Biobanking Market Size by Country (2027-2032)
- 7.4.4 North America Biobanking Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biobanking Market Size (2021-2032)
- 8.2 Europe Biobanking Market Size by Type
- 8.2.1 Europe Biobanking Market Size by Type (2021-2026)
- 8.2.2 Europe Biobanking Market Size by Type (2027-2032)
- 8.2.3 Europe Biobanking Market Share by Type (2021-2032)
- 8.3 Europe Biobanking Market Size by Application
- 8.3.1 Europe Biobanking Market Size by Application (2021-2026)
- 8.3.2 Europe Biobanking Market Size by Application (2027-2032)
- 8.3.3 Europe Biobanking Market Share by Application (2021-2032)
- 8.4 Europe Biobanking Market Size by Country
- 8.4.1 Europe Biobanking Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biobanking Market Size by Country (2021-2026)
- 8.4.3 Europe Biobanking Market Size by Country (2027-2032)
- 8.4.4 Europe Biobanking Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biobanking Market Size (2021-2032)
- 9.2 China Biobanking Market Size by Type
- 9.2.1 China Biobanking Market Size by Type (2021-2026)
- 9.2.2 China Biobanking Market Size by Type (2027-2032)
- 9.2.3 China Biobanking Market Share by Type (2021-2032)
- 9.3 China Biobanking Market Size by Application
- 9.3.1 China Biobanking Market Size by Application (2021-2026)
- 9.3.2 China Biobanking Market Size by Application (2027-2032)
- 9.3.3 China Biobanking Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biobanking Market Size (2021-2032)
- 10.2 Asia Biobanking Market Size by Type
- 10.2.1 Asia Biobanking Market Size by Type (2021-2026)
- 10.2.2 Asia Biobanking Market Size by Type (2027-2032)
- 10.2.3 Asia Biobanking Market Share by Type (2021-2032)
- 10.3 Asia Biobanking Market Size by Application
- 10.3.1 Asia Biobanking Market Size by Application (2021-2026)
- 10.3.2 Asia Biobanking Market Size by Application (2027-2032)
- 10.3.3 Asia Biobanking Market Share by Application (2021-2032)
- 10.4 Asia Biobanking Market Size by Country
- 10.4.1 Asia Biobanking Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biobanking Market Size by Country (2021-2026)
- 10.4.3 Asia Biobanking Market Size by Country (2027-2032)
- 10.4.4 Asia Biobanking Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biobanking Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biobanking Market Size by Type
- 11.2.1 South America, Middle East & Africa Biobanking Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biobanking Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biobanking Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biobanking Market Size by Application
- 11.3.1 South America, Middle East & Africa Biobanking Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biobanking Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biobanking Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biobanking Market Size by Country
- 11.4.1 South America, Middle East & Africa Biobanking Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biobanking Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biobanking Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biobanking Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst